Home › Cardiomyopathy › Missouri › Kansas City
Cardiomyopathy clinical trials in Kansas City, MO
3 studies for Cardiomyopathy are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ATR 1072 in Participants With PRKAG2 Syndrome
RecruitingPhase 1/2
- St Luke's Mid American Heart Institute, Kansas City
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- St. Luke's Hospital of Kansas City, Kansas City
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- St. Luke's Hospital, Kansas City
About Cardiomyopathy
Cardiomyopathy is a disease that causes the heart to become enlarged, thick, or stiff. Read about the different types, their symptoms, and treatments.
More about Cardiomyopathy on MedlinePlus
Cardiomyopathy trials in other cities
- New York City, NY10 studies
- Boston, MA9 studies
- Washington, DC8 studies
- Rochester, MN8 studies
- Baltimore, MD7 studies
- San Diego, CA7 studies
- Indianapolis, IN6 studies
- Richmond, VA6 studies
- Dallas, TX6 studies
- Philadelphia, PA6 studies
- St. Louis, MO6 studies
- Charleston, SC6 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer31 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer19 studies
- Colorectal Cancer16 studies
- Metastatic Cancer15 studies
- Acute Myeloid Leukemia15 studies
- Prostate Cancer14 studies
- Ovarian Cancer11 studies
- Obesity11 studies
- Type 2 Diabetes11 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.